Cantargia AB (CHIX:CANTAS) Shiller PE Ratio: (As of Sep. 21, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CHIX:CANTAS Cantargia AB CHIX:CANTAS
31 GF Score
Price kr4.17
! 3 Warning Signs
View Full Analysis

What is Cantargia AB Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Cantargia AB  (CHIX:CANTAs) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Cantargia AB Shiller PE Ratio Related Terms


Cantargia AB Shiller PE Ratio Historical Data

* Premium members only.

The historical data trend for Cantargia AB's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cantargia AB Shiller PE Ratio Chart

Cantargia AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Cantargia AB Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

CHIX:CANTAS vs VRTX, REGN, MRNA: Shiller PE Ratio Comparison

For the Biotechnology subindustry, Cantargia AB's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cantargia AB Shiller PE Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cantargia AB's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Cantargia AB's Shiller PE Ratio falls into.


CHIX:CANTAS
31GF Score
Cantargia AB CHIX:CANTAS
Shiller PE Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cantargia AB Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Cantargia AB's E10 for the quarter that ended in Jun. 2026 is calculated as:

For example, Cantargia AB's adjusted earnings per share data for the three months ended in Jun. 2026 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=-0.13/134.6100*134.6100
=-0.130

Current CPI (Jun. 2026) = 134.6100.

Cantargia AB Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201609 -0.579 101.138 -0.771
201612 -0.952 102.022 -1.256
201703 -0.541 102.022 -0.714
201706 -0.416 102.752 -0.545
201709 -0.291 103.279 -0.379
201712 -0.316 103.793 -0.410
201803 -0.175 103.962 -0.227
201806 -0.358 104.875 -0.460
201809 -0.266 105.679 -0.339
201812 -0.341 105.912 -0.433
201903 -0.300 105.886 -0.381
201906 -0.283 106.742 -0.357
201909 -0.300 107.214 -0.377
201912 -0.424 107.766 -0.530
202003 -0.408 106.563 -0.515
202006 -0.341 107.498 -0.427
202009 -0.358 107.635 -0.448
202012 -0.508 108.296 -0.631
202103 -0.599 108.360 -0.744
202106 -0.596 108.928 -0.737
202109 -0.865 110.338 -1.055
202112 -1.480 112.486 -1.771
202203 -1.170 114.825 -1.372
202206 -0.930 118.384 -1.057
202209 -0.490 122.296 -0.539
202212 -0.460 126.365 -0.490
202303 -0.450 127.042 -0.477
202306 -0.340 129.407 -0.354
202309 -0.460 130.224 -0.475
202312 -0.400 131.912 -0.408
202403 -0.200 132.205 -0.204
202406 -0.240 132.716 -0.243
202409 -0.230 132.304 -0.234
202412 -0.210 132.987 -0.213
202503 -0.190 132.825 -0.193
202506 -0.160 133.699 -0.161
202509 1.070 133.480 1.079
202512 -0.130 133.380 -0.131
202603 -0.130 133.550 -0.131
202606 -0.130 134.610 -0.130

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Cantargia AB Business Description

Other Exchanges CANTA:Sweden7V3:Germany
Address Scheelevagen 27, Lund, SWE, 223 63
Cantargia AB is a Swedish biotech company that develops targeted antibody-based drugs for cancer as well as autoimmune and inflammatory diseases. It has developed specific antibodies against IL1RAP to treat serious, life-threatening diseases. The company's development programme includes the candidate drugs nadunolimab (CAN04) and CAN10, both in the clinical development stage, which were latter acquired by Otsuka Pharmaceutical in 2025. In addition, the company is also developing a a pre-clinical project CAN14, derived from antibody platform CANxx. Geographically, the company's revenues have been generated in the markets of Japan and United States.
31GF Score

Get the complete analysis for CHIX:CANTAS

Shiller PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr4.17
Price